The GlobalHemophilia Management Market was worth USD 5.18 billion in 2017 and estimated to be growing at a CAGR of 1.62%, to reach USD 5.62 billion by 2022. Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting. Hemophilia usually occurs in males it is estimated that about 1 in 5000 males that are born each year contain hemophilia.